Pilot study shows clinical plausibility and safety of a new 5-nerve protocol, suggesting further rigorous trials are needed.
This 5-nerve protocol demonstrated clinical plausibility and safety. Lack of a control group precludes definitive attribution of improvements to RFA over placebo. Robust RCTs comparing 3-nerve vs. 5-nerve protocols are mandatory before clinical implementation.
No takes yet. Share an insight, caveat, or question.
Leoni et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: